文献速递免疫规划传染病防控与疫情报告

PLGA包封铜绿假单胞菌PopB疫苗抗原增强Th17应答并抵御实验性急性肺炎

PLGA-encapsulation of the Pseudomonas aeruginosa PopB vaccine antigen improves Th17 responses and confers protection against experimental acute pneumonia.
PubMed 文献 · Vaccine · 2018-10-09

本研究将铜绿假单胞菌III型分泌系统蛋白PopB/PcrH包封于PLGA纳米颗粒,经鼻免疫FVB/N小鼠,评估Th17应答及对致死剂量ExoU阳性PAO1急性肺部感染的保护效果。结果显示PLGA-PopB/PcrH组肺和脾Th17应答较空PLGA或单独PopB/PcrH组高3-4倍,攻毒后肺部细菌载量显著降低且生存改善。结论为PLGA包封PopB/PcrH可经鼻接种诱导Th17应答并保护小鼠抵抗急性致死性铜绿假单胞菌肺炎。

要点

  • PLGA包封PopB/PcrH经鼻免疫小鼠,肺和脾Th17应答提高3-4倍。
  • 攻毒后PLGA-PopB/PcrH组肺部细菌载量显著降低、生存改善。
  • 该疫苗保护作用依赖IL-17和CD4 Th17细胞。

核心结论

  • PLGA纳米颗粒包封PopB/PcrH可经鼻接种诱导Th17应答,并保护小鼠抵抗急性致死性铜绿假单胞菌肺炎。

研究设计与样本

  • 研究将重组PopB/PcrH或单独PcrH包封于PLGA纳米颗粒,以FVB/N小鼠经鼻免疫PLGA-PopB/PcrH、PLGA-PcrH、空PLGA或单独PopB/PcrH。
  • 采用致死剂量ExoU阳性铜绿假单胞菌PAO1急性肺部感染模型评估保护效果,用细胞内流式细胞术及脾细胞共培养上清ELISA检测Th17应答。

主要发现

  • PLGA-PopB/PcrH免疫小鼠肺和脾Th17应答较空PLGA或单独PopB/PcrH免疫小鼠高3-4倍。
  • 攻毒后PLGA-PopB/PcrH免疫小鼠肺部细菌载量显著降低且生存改善。

临床怎么用

  • 提示PLGA包封PopB/PcrH经鼻接种可作为诱导Th17应答、抵御铜绿假单胞菌急性肺炎的候选疫苗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Pseudomonas aeruginosa type III secretion system protein PopB and its chaperon protein PcrH, when co-administered with the adjuvant curdlan, elicit Th17 responses after intranasal immunization of mice. These PopB/PcrH-curdlan vaccines protect mice against acute lethal pneumonia in an IL-17-dependent fashion involving CD4 helper T cells secreting IL-17 (Th17 cells). In this study, we tested whether encapsulation of PopB/PcrH in poly-lactic-co-glycolic acid (PLGA) nanoparticles could elicit Th17 responses to PopB. Recombinant PopB/PcrH or PcrH alone was encapsulated into PLGA nanoparticles. Mice (FVB/N) were intranasally immunized with the PLGA-PopB/PcrH nanoparticles, PLGA-PcrH nanoparticles, PLGA alone, or PopB/PcrH alone. The protective efficacy was assessed in an acute lung infection model with a lethal dose of an ExoU-producing version of P. aeruginosa strain PAO1. Th17 responses were assayed by intracellular flow cytometry and by ELISA for IL-17 in supernatants of splenocytes co-cultured with purified PopB/PcrH. PLGA-PopB/PcrH-immunized mice showed 3-4-fold higher Th17 responses both in the lung and in the spleen compared to mice immunized with empty PLGA or PopB/PcrH alone. After challenge with P. aeruginosa, PLGA-PopB/PcrH-immunized mice showed significantly lower bacterial counts in the lungs and improved survival. In conclusion, encapsulation of PopB/PcrH in PLGA nanoparticles can elicit Th17 responses to intranasal vaccination and protect mice against acute lethal P. aeruginosa pneumonia.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Schaefers MM, Duan B, Mizrahi B, et al. PLGA-encapsulation of the Pseudomonas aeruginosa PopB vaccine antigen improves Th17 responses and confers protection against experimental acute pneumonia. Vaccine. 2018. PMID: 30314911. doi:10.1016/j.vaccine.2018.10.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。